Go to Pathways list
Support our work
DONATE NOW

Early breast cancer - Genomic signatures - the 3 Ws: Which, When, Why?

E-session 567001 / CME accredited
Add to My Agenda

Expert:

Hatem A. Azim Jr., expert of session 'Early breast cancer - Genomic signatures - the 3 Ws: Which, When, Why?'

Hatem A. Azim Jr.
Monterrey Institute of Technology
Monterrey, Mexico

Discussant:

Laura Van't Veer, expert of session 'Early breast cancer - Genomic signatures - the 3 Ws: Which, When, Why?'

Laura Van't Veer
University of California San Francisco
San Francisco, USA

Share on:

This session is part of the following pathway(s):

The role of systemic treatment in the multidisciplinary care of EARLY BREAST CANCER

In order to access to the CME test, please check the minimum system requirements.

Check the minimum system requirements

09
Apr 2021
18:15-19:00 CEST

Top